This issue examines current immunization guidelines for patients with hematologic disorders, considers medical education amid the coronavirus pandemic, and more.
This issue looks at how cost-effective analyses are used to inform health-care decisions, explains the latest maintenance of certification requirements, and more.
This supplement takes a look at the future of chemoimmunotherapy for chronic lymphocytic leukemia, the latest FDA approvals for the treatment of lymphoid and plasma cell malignancies, and more.
This issue examines the high price of treating hemophilia, asks whether CAR T-cell therapies are worth the cost, and more.
This issue features highlights from the 2019 ASH Annual Meeting, reflections on physician wellness, and more.
This issue features a discussion about value-based care initiatives, coverage of late-breaking abstracts presented at the 2019 ASH Annual Meeting, and more.
This issue examines the hidden costs of participating in clinical trials, explores the pediatric hematology/oncology workforce, and more.
This issue offers an inside look at this year’s annual meeting, advice for giving effective presentations, and more.
This issue features explores treating older patients with frailty, discusses the management of primary mediastinal B-cell lymphoma, and more.
This supplement explores new treatment options for hemophilia, gene therapy in nonmalignant hematologic disorders, and more.